These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12065903)

  • 1. Effect of extracellular matrix proteins on platelet-activating factor-induced eosinophil chemotaxis.
    Yoshikawa M; Matsumoto K; Iida M; Akasawa A; Moriyama H; Saito H
    Int Arch Allergy Immunol; 2002; 128 Suppl 1():3-11. PubMed ID: 12065903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines.
    Okada S; Kita H; George TJ; Gleich GJ; Leiferman KM
    Am J Respir Cell Mol Biol; 1997 Apr; 16(4):455-63. PubMed ID: 9115757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms involved in eosinophil migration. Platelet-activating factor-induced chemotaxis and interleukin-5-induced chemokinesis are mediated by different signals.
    Schweizer RC; van Kessel-Welmers BA; Warringa RA; Maikoe T; Raaijmakers JA; Lammers JW; Koenderman L
    J Leukoc Biol; 1996 Mar; 59(3):347-56. PubMed ID: 8604012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix proteins attenuate activation and degranulation of stimulated eosinophils.
    Kita H; Horie S; Gleich GJ
    J Immunol; 1996 Feb; 156(3):1174-81. PubMed ID: 8557995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
    J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptides modulate human eosinophil chemotaxis.
    Numao T; Agrawal DK
    J Immunol; 1992 Nov; 149(10):3309-15. PubMed ID: 1385521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants.
    Kishimoto S; Oka S; Gokoh M; Sugiura T
    Int Arch Allergy Immunol; 2006; 140 Suppl 1():3-7. PubMed ID: 16772720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
    el-Shazly AE; Masuyama K; Samejima Y; Eura M; Ishikawa T
    Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):587-95. PubMed ID: 8933171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
    Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA
    Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of alpha4 (CD49d) and beta2 (CD18) integrins in eosinophil and neutrophil migration to allergic lung inflammation in the Brown Norway rat.
    Schneider T; Issekutz TB; Issekutz AC
    Am J Respir Cell Mol Biol; 1999 Mar; 20(3):448-57. PubMed ID: 10030843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway epithelial cells promote transmigration of eosinophils in a new three-dimensional chemotaxis model.
    Kato Y; Fujisawa T; Shibano M; Saito T; Gatto W; Kamiya H; Hirai K; Sumida M; Yoshie O
    Clin Exp Allergy; 2002 Jun; 32(6):889-97. PubMed ID: 12047436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils.
    Fukuda T; Numao T; Akutsu I; Makino S
    J Lipid Mediat; 1992; 5(2):145-9. PubMed ID: 1525356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration.
    Kuijpers TW; Mul EP; Blom M; Kovach NL; Gaeta FC; Tollefson V; Elices MJ; Harlan JM
    J Exp Med; 1993 Jul; 178(1):279-84. PubMed ID: 7686213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
    Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
    Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory effect of substance P in human eosinophil migratory function.
    El-Shazly AE; Masuyama K; Eura M; Ishikawa T
    Immunol Invest; 1996 May; 25(3):191-201. PubMed ID: 9157054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the selectin binding polysaccharide fucoidin on eosinophil recruitment in vivo.
    Teixeira MM; Hellewell PG
    Br J Pharmacol; 1997 Mar; 120(6):1059-66. PubMed ID: 9134218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate.
    El-Shazly A; Masuyama K; Samejima Y; Eura M; Ishikawa T
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():10-3. PubMed ID: 9758889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine-induced adherence and migration of equine eosinophils.
    Foster AP; Cunningham FM
    Am J Vet Res; 1998 Sep; 59(9):1153-9. PubMed ID: 9736395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A surrogate method for assessment of beta(2)-integrin-dependent adhesion of human eosinophils to ICAM-1.
    Zhu X; Subbaraman R; Sano H; Jacobs B; Sano A; Boetticher E; Muñoz NM; Leff AR
    J Immunol Methods; 2000 Jun; 240(1-2):157-64. PubMed ID: 10854610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priming of eosinophil recruitment in vivo by LPS pretreatment.
    Macari DM; Teixeira MM; Hellewell PG
    J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.